Dual HER2 Targeted Therapy With Pyrotinib and Trastuzumab in Refractory HER2 Positive Metastatic Colorectal Cancer: A Result From HER2-FUSCC-G Study - Concepedia

Concepedia

Publication | Closed Access

Dual HER2 Targeted Therapy With Pyrotinib and Trastuzumab in Refractory HER2 Positive Metastatic Colorectal Cancer: A Result From HER2-FUSCC-G Study

32

Citations

20

References

2022

Year

Jinjia Chang, Midie Xu, Chenchen Wang, Dan Huang, Zhe Zhang, Zhiyu Chen, Xiaodong Zhu, Wenhua Li

Clinical Colorectal Cancer

Her2-fuscc-g StudyMedicineColorectal CancerPathologyCancer TreatmentRadiation OncologyOncologyCell BiologyMolecular Oncology

References

	Year	Citations

Page 1